Study to compare avelumab in combination with standard of care chemoradiotherapy (SoC CRT) versus SoC CRT for definitive treatment in patients with locally advanced squamous cell carcinoma of the head and neck (JAVELIN HEAD AND NECK 100)
A randomized double-blind phase 3 study of avelumab in combination with standard of care chemoradiotherapy (cisplatin plus definitive radiation therapy) versus standard of care chemoradiotherapy in the front-line treatment of patients with locally advanced squamous cell carcinoma of the head and neck
Category & Conditions: Cancer
Medicine: Bavencio (avelumab)
ClinicalTrials.gov Identifier (NCT): NCT02952586
Protocol ID: B9991016
PrintDownloadOpen Plain Language Summary Result: Click here